{
  "url": "https://openlegislation.uk/medicines-pharmacy-and-general-saleexemption-amendment-order-2003/note",
  "json_url": "https://openlegislation.uk/medicines-pharmacy-and-general-saleexemption-amendment-order-2003/note.json",
  "legislation": "uksi/2003/697",
  "legislation_title": "The Medicines (Pharmacy and General Sale—Exemption) Amendment Order 2003",
  "legislation_url": "https://openlegislation.uk/medicines-pharmacy-and-general-saleexemption-amendment-order-2003",
  "path": "note",
  "kind": "note",
  "number": null,
  "heading": "Explanatory note",
  "text": "(This note is not part of the Order)\nThis Order amends the Medicines (Pharmacy and General Sale—Exemption) Order 1980 (“the principal Order”) and provides for exemptions from sections 52 and 53 of the Medicines Act 1968 for the supply of a medicinal product for human use under a Patient Group Direction (i.e. a written direction providing for the supply of a description or class of medicines to persons generally) to assist the provision of health care by certain non-NHS health care providers (i.e. a provider of health care other than a National Health Service body or a person providing services under an arrangement with such a body). In particular, article 3 inserts new articles 4C and 4D of the principal Order—\n(a) article 4C provides for the supply of medicinal products for human use by designated health professionals in the course of the business of an independent hospital, clinic or agency, or nursing home, in accordance with a Patient Group Direction; and\n(b) article 4D provides for the supply of medicinal products for human use by designated health professionals in order to assist the provision of health care by or on behalf of the police, the prison services or the armed forces, in accordance with a Patient Group Direction.\nArticle 4 inserts new Part IIA of Schedule 3 to the principal Order, which specifies the persons by whom or on whose behalf a Patient Group Direction for the police, prison services or armed forces must be signed.\nA Regulatory Impact Assessment in relation to this Order has been placed in the libraries of both Houses of Parliament and copies may be obtained from the Department of Health, Medicines Control Agency, Information Centre, Room 10-202, Market Towers, 1 Nine Elms Lane, London SW8 5NQ.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2003/697/note",
    "retrieved_at": "2026-10-29T06:28:55.753635+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}